Gerald Li

12PUBLICATIONS
84CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 14, 2026
Clinical, genomic, and spatial transcriptomic features of pancreatic adenosquamous carcinoma support subtype-specific therapeutic strategies.

|Aug 13, 2026
SPEN inactivation drives resistance to androgen receptor pathway inhibitors in metastatic prostate cancer.

|May 14, 2026
Homozygous Loss of Recombination Repair Genes and Poly ADP-Ribose Polymerase Inhibitor Benefit for Patients With Ovarian Cancer.

|Dec 04, 2025
Additive Clinical Utility of Microsatellite Instability and Tumor Mutational Burden to Predict Immune Checkpoint Inhibitor Effectiveness in Metastatic Castration-Resistant Prostate Cancer.

Nicolas Sayegh, Ryon P Graf, Umang Swami

|Oct 09, 2025
LRP1b Loss Predicts Sensitivity to Immunotherapy in Patients with NSCLC: An Analysis of the Phase III CheckMate-026 Randomized Trial.

Andrew J Armstrong, Hilary Dietz, David Balli

|Jun 23, 2025
Clinical utility of companion diagnostic biomarker results below the limit of detection in comprehensive genomic profiling of patients with advanced non-small cell lung cancer.

Gerald Li, Stephanie B Greene, Baljinder Kaur

Pageof 2

Frequent Collaborators

11 joint publications

Ryon P Graf

5 joint publications

Jeffrey S Ross

4 joint publications

Richard S P Huang

3 joint publications

Umang Swami